Filter announcements
Loading...
Zenotech Laboratories Ltd is in the business of manufacturing biotechnology productsBusiness Overview: ZTLL is a part of Sun Pharmaceuticals Industries Ltd. It does manufacturing and marketing of pharmaceuticals and bio-pharmaceutical products. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing Oncology, bio-technology and General Injectables...
Zenotech Laboratories Limited has announced the publication of newspaper advertisements detailing its 37th Annual General Meeting and electronic voting facility. These ads, appearing in Business Standard and Telugu Prabha, aim to inform shareholders about the upcoming meeting and their opportunity to participate in company decisions. Full details, including procedures for...
ZENOTECH LABORATORIES has announced its 37th Annual General Meeting (AGM) will be held on Friday, September 25, 2026, at 10:30 a.m. IST via Video Conferencing. The company has published newspaper advertisements to inform shareholders. Members can access the AGM notice and annual report on the company's website and stock exchange...
**ZENOTECH LABORATORIES LIMITED** Zenotech Laboratories has announced its financial results for the quarter ended June 30, 2026. The Board of Directors reviewed and approved these results in a meeting held on July 28, 2026. For the quarter, the company reported a total income from operations (net) of Rs 11.05 Cr....
Zenotech Laboratories Limited has submitted a compliance certificate from its Registrar and Share Transfer Agent for the quarter ended June 30. The certificate confirms the smooth processing of dematerialization requests. It ensures that securities received were appropriately confirmed to depositories, listed on exchanges, and physical certificates were cancelled with updated...
Zenotech Laboratories has released its audited financial results for the quarter and year ended March 31, 2026. For the quarter, total income from operations reached ₹12.62 Cr, resulting in a net profit of ₹1.23 Cr and an EPS of ₹0.20. The full fiscal year saw total income at ₹44.60 Cr...